Share Price and Basic Stock Data
Last Updated: February 25, 2025, 5:17 am
PEG Ratio | 3.02 |
---|
Competitors of KSB Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Hawa Engineers Ltd | 42.0 Cr. | 119 | 338/113 | 22.7 | 55.9 | 0.00 % | 14.7 % | 10.4 % | 10.0 |
Shakti Pumps (India) Ltd | 10,687 Cr. | 889 | 1,398/187 | 27.6 | 78.4 | 0.07 % | 31.4 % | 24.2 % | 10.0 |
Latteys Industries Ltd | 110 Cr. | 19.1 | 48.6/13.0 | 67.9 | 3.40 | 0.00 % | 11.8 % | 9.00 % | 2.00 |
Bright Solar Ltd | 7.00 Cr. | 2.80 | 11.8/2.80 | 11.8 | 0.00 % | 10.9 % | 11.5 % | 10.0 | |
Kirloskar Brothers Ltd | 13,782 Cr. | 1,736 | 2,685/907 | 31.7 | 233 | 0.35 % | 27.3 % | 21.7 % | 2.00 |
Industry Average | 8,860.75 Cr | 564.98 | 39.46 | 76.68 | 0.16% | 19.90% | 15.65% | 6.00 |
Quarterly Result
Metric | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 303 | 368 | 445 | 418 | 448 | 431 | 525 | 490 | 591 | 564 | 603 | 544 | 646 |
Expenses | 264 | 316 | 388 | 363 | 387 | 377 | 448 | 432 | 506 | 493 | 522 | 483 | 555 |
Operating Profit | 39 | 52 | 56 | 55 | 61 | 54 | 77 | 57 | 85 | 70 | 81 | 61 | 91 |
OPM % | 13% | 14% | 13% | 13% | 14% | 13% | 15% | 12% | 14% | 12% | 13% | 11% | 14% |
Other Income | 10 | 11 | 10 | 11 | 15 | 12 | 11 | 10 | 11 | 11 | 9 | 13 | 13 |
Interest | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 |
Depreciation | 11 | 11 | 11 | 10 | 11 | 12 | 12 | 12 | 12 | 12 | 14 | 13 | 13 |
Profit before tax | 37 | 51 | 54 | 55 | 64 | 53 | 73 | 55 | 83 | 67 | 75 | 60 | 90 |
Tax % | 27% | 23% | 27% | 26% | 26% | 27% | 24% | 26% | 24% | 25% | 27% | 25% | 24% |
Net Profit | 27 | 39 | 39 | 40 | 47 | 39 | 56 | 41 | 63 | 50 | 55 | 45 | 68 |
EPS in Rs | 1.56 | 2.24 | 2.26 | 2.32 | 2.72 | 2.24 | 3.21 | 2.35 | 3.61 | 2.88 | 3.16 | 2.56 | 3.91 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 714 | 731 | 802 | 819 | 826 | 946 | 1,093 | 1,294 | 1,208 | 1,497 | 1,822 | 2,247 |
Expenses | 621 | 629 | 701 | 713 | 720 | 838 | 965 | 1,142 | 1,039 | 1,287 | 1,575 | 1,954 |
Operating Profit | 93 | 102 | 101 | 106 | 106 | 108 | 128 | 152 | 169 | 210 | 247 | 294 |
OPM % | 13% | 14% | 13% | 13% | 13% | 11% | 12% | 12% | 14% | 14% | 14% | 13% |
Other Income | 14 | 12 | 23 | 24 | 29 | 35 | 24 | 40 | 33 | 40 | 50 | 42 |
Interest | 5 | 3 | 2 | 2 | 3 | 4 | 4 | 5 | 3 | 5 | 6 | 5 |
Depreciation | 24 | 27 | 28 | 28 | 29 | 31 | 40 | 46 | 42 | 44 | 45 | 50 |
Profit before tax | 79 | 86 | 94 | 100 | 103 | 108 | 109 | 140 | 157 | 201 | 245 | 280 |
Tax % | 30% | 33% | 34% | 36% | 33% | 34% | 34% | 28% | 40% | 26% | 25% | 26% |
Net Profit | 64 | 67 | 68 | 69 | 69 | 71 | 72 | 101 | 94 | 149 | 183 | 209 |
EPS in Rs | 18.27 | 19.18 | 19.66 | 19.75 | 19.69 | 20.37 | 20.57 | 28.94 | 26.94 | 42.92 | 52.50 | 59.96 |
Dividend Payout % | 30% | 29% | 28% | 28% | 28% | 29% | 29% | 28% | 32% | 29% | 29% | 29% |
YoY Net Profit Growth
Year |
---|
YoY Net Profit Growth (%) |
Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 16% |
3 Years: | 23% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 24% |
3 Years: | 30% |
TTM: | 9% |
Stock Price CAGR | |
---|---|
10 Years: | 16% |
5 Years: | 36% |
3 Years: | 46% |
1 Year: | -21% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 15% |
3 Years: | 17% |
Last Year: | 17% |
Last Updated: Unknown
Balance Sheet
Last Updated: Unknown
Month | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
Reserves | 433 | 477 | 522 | 568 | 625 | 676 | 723 | 794 | 856 | 976 | 1,108 | 1,267 | 1,316 |
Borrowings | 17 | 3 | 24 | 1 | 7 | 13 | 43 | 60 | 62 | 3 | 3 | 3 | 3 |
Other Liabilities | 269 | 284 | 332 | 347 | 321 | 354 | 449 | 547 | 588 | 596 | 679 | 761 | 879 |
Total Liabilities | 754 | 799 | 914 | 951 | 988 | 1,077 | 1,250 | 1,436 | 1,540 | 1,609 | 1,825 | 2,066 | 2,232 |
Fixed Assets | 158 | 181 | 191 | 194 | 219 | 308 | 321 | 307 | 318 | 311 | 350 | 419 | 424 |
CWIP | 27 | 8 | 10 | 14 | 16 | 4 | 4 | 34 | 25 | 39 | 25 | 32 | 37 |
Investments | 43 | 48 | 50 | 51 | 54 | 58 | 60 | 64 | 66 | 70 | 74 | 80 | 81 |
Other Assets | 526 | 561 | 663 | 691 | 699 | 707 | 865 | 1,030 | 1,130 | 1,190 | 1,375 | 1,535 | 1,691 |
Total Assets | 754 | 799 | 914 | 951 | 988 | 1,077 | 1,250 | 1,436 | 1,540 | 1,609 | 1,825 | 2,066 | 2,232 |
Cash Flow
Month | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 76.00 | 99.00 | 77.00 | 105.00 | 99.00 | 95.00 | 85.00 | 92.00 | 107.00 | 207.00 | 244.00 | 291.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 75 | 63 | 82 | 80 | 72 | 98 | 97 | 84 | 81 | 68 | 81 | 80 |
Inventory Days | 197 | 194 | 193 | 171 | 200 | 193 | 196 | 170 | 212 | 195 | 207 | 184 |
Days Payable | 114 | 138 | 147 | 145 | 142 | 139 | 141 | 127 | 155 | 129 | 116 | 98 |
Cash Conversion Cycle | 158 | 120 | 127 | 106 | 130 | 153 | 152 | 127 | 138 | 134 | 172 | 165 |
Working Capital Days | 63 | 41 | 56 | 40 | 60 | 88 | 85 | 54 | 44 | 54 | 76 | 77 |
ROCE % | 17% | 18% | 17% | 17% | 17% | 16% | 15% | 16% | 18% | 21% | 23% | 23% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Nippon India ELSS Tax Saver Fund | 715,000 | 1.84 | 260.85 | 189,783 | 2025-02-23 | 276.75% |
Tata Small Cap Fund | 411,118 | 2.45 | 149.99 | 189,783 | 2025-02-23 | 116.63% |
Sundaram Small Cap Fund | 248,570 | 2.96 | 90.68 | 189,783 | 2025-02-23 | 30.98% |
Sundaram Multi Cap Fund | 189,783 | 2.89 | 69.24 | 189,783 | 2025-02-23 | 0% |
Motilal Oswal ELSS Tax Saver Fund | 169,047 | 2.04 | 61.67 | 189,783 | 2025-02-23 | -10.93% |
Tata Infrastructure Fund - Regular Plan | 112,000 | 2.4 | 40.86 | 189,783 | 2025-02-23 | -40.99% |
WhiteOak Capital Flexi Cap Fund | 89,138 | 1.09 | 32.52 | 189,783 | 2025-02-23 | -53.03% |
Bank of India Small Cap Fund | 65,129 | 2.61 | 23.76 | 189,783 | 2025-02-23 | -65.68% |
ITI Small Cap Fund | 62,293 | 1.09 | 22.73 | 189,783 | 2025-02-23 | -67.18% |
Sundaram Infrastructure Advantage Fund | 57,000 | 2.46 | 20.8 | 189,783 | 2025-02-23 | -69.97% |
Key Financial Ratios
Month | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 59.97 | 52.50 | 42.92 | 26.94 | 28.94 |
Diluted EPS (Rs.) | 59.97 | 52.50 | 42.92 | 26.94 | 28.94 |
Cash EPS (Rs.) | 71.53 | 63.26 | 53.58 | 37.42 | 40.52 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 374.02 | 328.41 | 290.40 | 255.87 | 238.07 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 374.02 | 328.41 | 290.40 | 255.87 | 238.07 |
Revenue From Operations / Share (Rs.) | 645.61 | 523.43 | 430.16 | 347.08 | 371.73 |
PBDIT / Share (Rs.) | 93.63 | 82.98 | 69.86 | 56.54 | 49.81 |
PBIT / Share (Rs.) | 79.36 | 69.97 | 57.35 | 44.54 | 36.67 |
PBT / Share (Rs.) | 77.84 | 68.22 | 55.90 | 43.57 | 38.81 |
Net Profit / Share (Rs.) | 57.26 | 50.25 | 41.07 | 25.42 | 27.38 |
NP After MI And SOA / Share (Rs.) | 59.97 | 52.50 | 42.92 | 26.94 | 28.94 |
PBDIT Margin (%) | 14.50 | 15.85 | 16.24 | 16.29 | 13.39 |
PBIT Margin (%) | 12.29 | 13.36 | 13.33 | 12.83 | 9.86 |
PBT Margin (%) | 12.05 | 13.03 | 12.99 | 12.55 | 10.43 |
Net Profit Margin (%) | 8.86 | 9.60 | 9.54 | 7.32 | 7.36 |
NP After MI And SOA Margin (%) | 9.28 | 10.02 | 9.97 | 7.76 | 7.78 |
Return on Networth / Equity (%) | 16.03 | 15.98 | 14.77 | 10.53 | 12.15 |
Return on Capital Employeed (%) | 20.47 | 20.47 | 18.75 | 16.54 | 14.65 |
Return On Assets (%) | 10.10 | 10.01 | 9.28 | 6.08 | 7.01 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.06 | 0.07 |
Asset Turnover Ratio (%) | 1.16 | 1.06 | 0.96 | 0.82 | 0.98 |
Current Ratio (X) | 2.05 | 2.01 | 2.06 | 1.81 | 1.75 |
Quick Ratio (X) | 1.15 | 1.12 | 1.28 | 1.21 | 1.17 |
Inventory Turnover Ratio (X) | 1.78 | 1.82 | 1.84 | 1.61 | 1.92 |
Dividend Payout Ratio (NP) (%) | 25.01 | 23.80 | 19.80 | 29.69 | 20.73 |
Dividend Payout Ratio (CP) (%) | 20.20 | 19.08 | 15.33 | 20.54 | 14.26 |
Earning Retention Ratio (%) | 74.99 | 76.20 | 80.20 | 70.31 | 79.27 |
Cash Earning Retention Ratio (%) | 79.80 | 80.92 | 84.67 | 79.46 | 85.74 |
Interest Coverage Ratio (X) | 61.61 | 47.15 | 48.25 | 57.99 | 32.64 |
Interest Coverage Ratio (Post Tax) (X) | 38.68 | 29.55 | 29.37 | 27.07 | 16.55 |
Enterprise Value (Cr.) | 11783.45 | 6480.95 | 3876.03 | 1908.03 | 2119.50 |
EV / Net Operating Revenue (X) | 5.24 | 3.56 | 2.59 | 1.58 | 1.64 |
EV / EBITDA (X) | 36.16 | 22.44 | 15.94 | 9.69 | 12.23 |
MarketCap / Net Operating Revenue (X) | 5.37 | 3.70 | 2.83 | 1.86 | 1.82 |
Retention Ratios (%) | 74.98 | 76.19 | 80.19 | 70.30 | 79.26 |
Price / BV (X) | 9.26 | 5.90 | 4.19 | 2.53 | 2.84 |
Price / Net Operating Revenue (X) | 5.37 | 3.70 | 2.83 | 1.86 | 1.82 |
EarningsYield | 0.01 | 0.02 | 0.03 | 0.04 | 0.04 |
After reviewing the key financial ratios for KSB Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Dec 23, the value is 59.97. This value is within the healthy range. It has increased from 52.50 (Dec 22) to 59.97, marking an increase of 7.47.
- For Diluted EPS (Rs.), as of Dec 23, the value is 59.97. This value is within the healthy range. It has increased from 52.50 (Dec 22) to 59.97, marking an increase of 7.47.
- For Cash EPS (Rs.), as of Dec 23, the value is 71.53. This value is within the healthy range. It has increased from 63.26 (Dec 22) to 71.53, marking an increase of 8.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 374.02. It has increased from 328.41 (Dec 22) to 374.02, marking an increase of 45.61.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 374.02. It has increased from 328.41 (Dec 22) to 374.02, marking an increase of 45.61.
- For Revenue From Operations / Share (Rs.), as of Dec 23, the value is 645.61. It has increased from 523.43 (Dec 22) to 645.61, marking an increase of 122.18.
- For PBDIT / Share (Rs.), as of Dec 23, the value is 93.63. This value is within the healthy range. It has increased from 82.98 (Dec 22) to 93.63, marking an increase of 10.65.
- For PBIT / Share (Rs.), as of Dec 23, the value is 79.36. This value is within the healthy range. It has increased from 69.97 (Dec 22) to 79.36, marking an increase of 9.39.
- For PBT / Share (Rs.), as of Dec 23, the value is 77.84. This value is within the healthy range. It has increased from 68.22 (Dec 22) to 77.84, marking an increase of 9.62.
- For Net Profit / Share (Rs.), as of Dec 23, the value is 57.26. This value is within the healthy range. It has increased from 50.25 (Dec 22) to 57.26, marking an increase of 7.01.
- For NP After MI And SOA / Share (Rs.), as of Dec 23, the value is 59.97. This value is within the healthy range. It has increased from 52.50 (Dec 22) to 59.97, marking an increase of 7.47.
- For PBDIT Margin (%), as of Dec 23, the value is 14.50. This value is within the healthy range. It has decreased from 15.85 (Dec 22) to 14.50, marking a decrease of 1.35.
- For PBIT Margin (%), as of Dec 23, the value is 12.29. This value is within the healthy range. It has decreased from 13.36 (Dec 22) to 12.29, marking a decrease of 1.07.
- For PBT Margin (%), as of Dec 23, the value is 12.05. This value is within the healthy range. It has decreased from 13.03 (Dec 22) to 12.05, marking a decrease of 0.98.
- For Net Profit Margin (%), as of Dec 23, the value is 8.86. This value is within the healthy range. It has decreased from 9.60 (Dec 22) to 8.86, marking a decrease of 0.74.
- For NP After MI And SOA Margin (%), as of Dec 23, the value is 9.28. This value is within the healthy range. It has decreased from 10.02 (Dec 22) to 9.28, marking a decrease of 0.74.
- For Return on Networth / Equity (%), as of Dec 23, the value is 16.03. This value is within the healthy range. It has increased from 15.98 (Dec 22) to 16.03, marking an increase of 0.05.
- For Return on Capital Employeed (%), as of Dec 23, the value is 20.47. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 20.47.
- For Return On Assets (%), as of Dec 23, the value is 10.10. This value is within the healthy range. It has increased from 10.01 (Dec 22) to 10.10, marking an increase of 0.09.
- For Total Debt / Equity (X), as of Dec 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Dec 23, the value is 1.16. It has increased from 1.06 (Dec 22) to 1.16, marking an increase of 0.10.
- For Current Ratio (X), as of Dec 23, the value is 2.05. This value is within the healthy range. It has increased from 2.01 (Dec 22) to 2.05, marking an increase of 0.04.
- For Quick Ratio (X), as of Dec 23, the value is 1.15. This value is within the healthy range. It has increased from 1.12 (Dec 22) to 1.15, marking an increase of 0.03.
- For Inventory Turnover Ratio (X), as of Dec 23, the value is 1.78. This value is below the healthy minimum of 4. It has decreased from 1.82 (Dec 22) to 1.78, marking a decrease of 0.04.
- For Dividend Payout Ratio (NP) (%), as of Dec 23, the value is 25.01. This value is within the healthy range. It has increased from 23.80 (Dec 22) to 25.01, marking an increase of 1.21.
- For Dividend Payout Ratio (CP) (%), as of Dec 23, the value is 20.20. This value is within the healthy range. It has increased from 19.08 (Dec 22) to 20.20, marking an increase of 1.12.
- For Earning Retention Ratio (%), as of Dec 23, the value is 74.99. This value exceeds the healthy maximum of 70. It has decreased from 76.20 (Dec 22) to 74.99, marking a decrease of 1.21.
- For Cash Earning Retention Ratio (%), as of Dec 23, the value is 79.80. This value exceeds the healthy maximum of 70. It has decreased from 80.92 (Dec 22) to 79.80, marking a decrease of 1.12.
- For Interest Coverage Ratio (X), as of Dec 23, the value is 61.61. This value is within the healthy range. It has increased from 47.15 (Dec 22) to 61.61, marking an increase of 14.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 23, the value is 38.68. This value is within the healthy range. It has increased from 29.55 (Dec 22) to 38.68, marking an increase of 9.13.
- For Enterprise Value (Cr.), as of Dec 23, the value is 11,783.45. It has increased from 6,480.95 (Dec 22) to 11,783.45, marking an increase of 5,302.50.
- For EV / Net Operating Revenue (X), as of Dec 23, the value is 5.24. This value exceeds the healthy maximum of 3. It has increased from 3.56 (Dec 22) to 5.24, marking an increase of 1.68.
- For EV / EBITDA (X), as of Dec 23, the value is 36.16. This value exceeds the healthy maximum of 15. It has increased from 22.44 (Dec 22) to 36.16, marking an increase of 13.72.
- For MarketCap / Net Operating Revenue (X), as of Dec 23, the value is 5.37. This value exceeds the healthy maximum of 3. It has increased from 3.70 (Dec 22) to 5.37, marking an increase of 1.67.
- For Retention Ratios (%), as of Dec 23, the value is 74.98. This value exceeds the healthy maximum of 70. It has decreased from 76.19 (Dec 22) to 74.98, marking a decrease of 1.21.
- For Price / BV (X), as of Dec 23, the value is 9.26. This value exceeds the healthy maximum of 3. It has increased from 5.90 (Dec 22) to 9.26, marking an increase of 3.36.
- For Price / Net Operating Revenue (X), as of Dec 23, the value is 5.37. This value exceeds the healthy maximum of 3. It has increased from 3.70 (Dec 22) to 5.37, marking an increase of 1.67.
- For EarningsYield, as of Dec 23, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Dec 22) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in KSB Ltd:
- Net Profit Margin: 8.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.47% (Industry Average ROCE: 19.9%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.03% (Industry Average ROE: 15.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 38.68
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.15
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 47.4 (Industry average Stock P/E: 39.46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.86%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Pumps | Office No. 601, Mumbai Maharashtra 400080 | compsec.india@ksb.com http://www.ksbindia.co.in |
Management | |
---|---|
Name | Position Held |
Mr. Gaurav Swarup | Chairman, Non Ind & Non Exe Director |
Mr. Rajeev Jain | Managing Director |
Dr. Stephan Bross | Non Executive Director |
Dr. Matthias Schmitz | Non Executive Director |
Mr. V K Viswanathan | Ind. Non-Executive Director |
Ms. Sharmila Barua Roychowdhury | Ind. Non-Executive Director |
Mr. Dara N Damania | Ind. Non-Executive Director |
Mr. Pradip Shah | Ind. Non-Executive Director |
FAQ
What is the latest intrinsic value of KSB Ltd?
Let's break down KSB Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 25 February 2025:
- Calculated Fair Value: ₹506.00
- Current Market Price: ₹624.00
- Variance: 18.91% lower
This suggests KSB Ltd is currently overvalued by 18.91%. For context:
- Market Cap: 10,864 Cr.
- 52-Week Range: 1,060/582
- Reserves (Jun 2024): ₹1,316 Cr
- Liabilities: 2,232 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of KSB Ltd?
The Market Cap of KSB Ltd is 10,864 Cr..
What is the current Stock Price of KSB Ltd as on 25 February 2025?
The current stock price of KSB Ltd as on 25 February 2025 is ₹624.
What is the High / Low of KSB Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of KSB Ltd stocks is 1,060/582.
What is the Stock P/E of KSB Ltd?
The Stock P/E of KSB Ltd is 47.4.
What is the Book Value of KSB Ltd?
The Book Value of KSB Ltd is 77.6.
What is the Dividend Yield of KSB Ltd?
The Dividend Yield of KSB Ltd is 0.56 %.
What is the ROCE of KSB Ltd?
The ROCE of KSB Ltd is 23.3 %.
What is the ROE of KSB Ltd?
The ROE of KSB Ltd is 17.1 %.
What is the Face Value of KSB Ltd?
The Face Value of KSB Ltd is 2.00.